SCHEMBL12137691

SCHEMBL12137691

CC(C)Oc1cccc(-c2nc(N)nc(N)c2-c2cccnc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.45
▸ ADORA2A P29274 7/20 0.44
▸ ADORA1 P30542 4/20 0.44
▸ DHFR P00374 1/20 0.44
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ KDM4E B2RXH2 4/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ PDE4B Q07343 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ ADORA2B P29275 3/20 0.39
▸ NQO2 P16083 2/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12137688 0.87 PIK3CG (0.55) ADORA2AADORA1PIK3CGKDM4ENPSR1
SCHEMBL12137704 0.81 NPY5R (0.51) ADORA2AADORA1DHFRMAPTATR
SCHEMBL12135533 0.81 ADORA2A (0.41) MAP4K4ADORA2AADORA1DHFRPIK3CG
SCHEMBL12137432 0.79 ADORA2A (0.54) ADORA2AADORA1PIK3CGKDM4ENPSR1
SCHEMBL12137698 0.77 ADORA2A (0.60) ADORA2AADORA1DHFRPIK3CGKDM4E
SCHEMBL12138069 0.77 KDM4E (0.60) ADORA2AADORA1KDM4ENPSR1RXFP1
SCHEMBL12137469 0.76 NPC1 (0.53) ADORA1MKNK1MKNK2KDM4EMAPT
SCHEMBL12137900 0.76 ADORA2A (0.50) ADORA2AADORA1DHFRKDM4ENPSR1
SCHEMBL12137898 0.75 KDM4E (0.48) ADORA2AADORA1KDM4ENPSR1RXFP1
SCHEMBL12137470 0.75 CYP1A2 (0.52) ADORA2AADORA1ATRCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 MAP4K4 1853/4885ADORA2A 314/4885ADORA1 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback